Thirona is now compliant with the new Medical Device Regulation

The new EU Medical Device Regulation (MDR) 2017/745, which will come into full effect in May 2021, has a major impact on medical device manufacturers worldwide. Implementation of the new regulations has manufacturers facing challenges due to the stricter rules, limited resources, and lack of clear EU guidance. Therefore, we are especially proud to announce that Thirona successfully implemented the requirements and we are now certified against the new MDR.

Thirona obtains patent for quantitative analysis of Cystic Fibrosis in children

Thirona has obtained an exclusive license on a patent in relation to Cystic Fibrosis (CF),  a rare genetic condition that creates lung abnormalities from a very early age. The patent allows us to develop an AI algorithm that will analyse CT scans to identify even the smallest abnormalities in the lungs, especially early on, ensuring that the right treatment can follow.


Artificial Intelligence for analysis of chest CT images

Thirona’s lung quantification software offers analysis of chest CT scans that aids in the detection, evaluation, and treatment planning of lung diseases.

Learn more

Artificial intelligence for analysis of chest X-ray images

CAD4TB is a computer-aided detection system that can detect tuberculosis-related abnormalities in posterior-anterior chest X-rays.

Learn more

Artificial Intelligence for analysis of retina images

RetCAD is a computer-aided detection system that detects abnormalities related to Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR).

Learn more

Certified image analysis service

Thirona offers quantitative image analysis through ISO 13485-certified Image Analysis Service to ensure high-quality results.

Learn more
Go to Top